Ostagenin Max Ingredients & Drug Interactions
by EPG
What is this page for?
First and foremost: checking Ostagenin Max against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Ostagenin Max is a dietary supplement by EPG with 2 active ingredients. Its ingredients are commonly taken for muscle building, athletic performance, fat loss / body recomposition.Based on those ingredients, 611 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Ostagenin Max by EPG
Ask about any prescription or over-the-counter medication and we check it for interactions with Ostagenin Max by EPG — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Ostagenin Max by EPG
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
Ostagenin Max contains 2 active ingredients: 5a-Hydroxy Laxogenin and ostarine (a selective androgen receptor modulator, or SARM). Ostarine is a research compound that's under investigation for muscle-wasting conditions and bone health.
The product also contains inactive ingredients — gelatin capsule material, magnesium stearate, and rice flour.
Does it work?
Not established
The evidence for ostarine isn't established in the data we hold. Studies have looked at it for athletic performance, cancer-related muscle loss (cachexia), muscular dystrophy, sarcopenia (age-related muscle loss), and breast cancer, but the reliable evidence is insufficient to rate how well it works for any of these.
We also don't have effectiveness data on file for 5a-Hydroxy Laxogenin.
How safe is it?
Well-documented data
Ostarine carries serious safety concerns. It's an unapproved investigational drug — the FDA has not approved it for human use and has warned about supplements containing SARMs like ostarine because of documented safety risks.
The most common side effects reported in studies are stomach pain, loss of appetite, constipation, diarrhea, nausea, and temporary increases in liver enzymes (ALT). Liver damage (hepatotoxicity), though rare, has been documented.
In clinical trials, some people also experienced low red blood cells (anemia) and low platelets (thrombocytopenia). Because ostarine affects hormone pathways, the safety data advises against use during pregnancy and breastfeeding.
Meds to double-check
Moderate interaction found
Before taking Ostagenin Max, check with your pharmacist if you take any medications that damage the liver, any liver enzyme inhibitors or inducers (including rifampin and probenecid), or drugs that are metabolized by your liver's CYP3A4 or CYP2C9 systems. Ostarine interacts with a large number of medications — the checker on this page will help you identify your specific risks.
The bottom line
Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Moderate medication interactions have been identified, and safety information is well characterized.
Ostagenin Max contains an unapproved research compound with documented liver and blood-related risks and no established effectiveness for any condition. If you're considering it, talk with your pharmacist or doctor first — especially if you take any medications or have liver concerns.
This is not a product to start without professional guidance.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 2 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Nov 21, 2018.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Ostagenin Max, straight from the product label.
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Ostagenin Max by EPG, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| 5a-Hydroxy Laxogenin | 100 mg | -- |
| (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide | 25 mg | -- |
Other ingredients: Gelatin, Magnesium Stearate, Rice Flour
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula
100 mg 5a-Hydroxy Laxogenin 25 mg Ostarin (MK-2866) (Per Serving)
General Statements
Increases Protein Synthesis 200% Enhance Natural Hormones Lean Muscle Gains Effective synergy of 2 great components
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Suggested Use: Men: Take 2 capsules per day.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Ostagenin Max by EPG label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Ostagenin Max by EPG
These are the 2 active ingredients this product is made of. Select any to open its full monograph.
Serving size2 Capsule(s) Dosage formCapsule Servings per container30 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
5a-Hydroxy Laxogenin
(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide
Interacts with611 drugs
Ostarine (also called MK-2866 or enobosarm) is an experimental, unapproved drug known as a SARM (selective androgen receptor modulator), not a true di...
(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide monograph & interactionsOther (inactive) ingredients: Gelatin, Magnesium Stearate, Rice Flour. These complete the product’s ingredient list but are not active constituents.
Ostagenin Max by EPG Drug Interactions
HelloPharmacist Interaction Report
Ostagenin Max contains ostarine, a compound that interacts with a significant number of medications.
The most serious concern is with drugs that damage the liver (hepatotoxic drugs) — ostarine itself can raise liver enzyme markers in some people, and combining it with other liver-damaging substances increases that risk further.
Read the full breakdown — every affected drug type, severity by severity
Ostarine is also metabolized by your liver's enzyme systems, which creates several moderate-level interactions. If you take rifampin (an antibiotic), it speeds up how your body clears ostarine, potentially reducing its effects.
The opposite happens with probenecid (a gout medication) — it slows ostarine clearance and raises its levels. Additionally, ostarine may interact with drugs that inhibit or induce the CYP3A4 enzyme system; these interactions are generally minor, though some enzyme inducers can weaken ostarine's effects.
We could not check the interaction data for 5a-Hydroxy Laxogenin, the other active ingredient in this product. Altogether, these interactions span 593 individual medications.
Use the medication checker on this page to look up any prescription or over-the-counter drugs you take before starting Ostagenin Max.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Ostagenin Max?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Ostagenin Max interact with 611 drugs. Click any drug to see the details.
1 of the 2 ingredients in Ostagenin Max interact with drugs. Each result below shows which ingredient is responsible. (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide
DapsoneAczone, Avlosulfon, Dapsone
How Dapsone interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dapsone interactionDarunavir, Cobicistat, Emtricitabine, Tenofovir AlafenamideSymtuza
How Darunavir, Cobicistat, Emtricitabine, Tenofovir Alafenamide interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Darunavir, Cobicistat, Emtricitabine, Tenofovir Alafenamide interactionDasabuvir Sodium, Ombitasvir, Paritaprevir, RitonavirViekira XR
How Dasabuvir Sodium, Ombitasvir, Paritaprevir, Ritonavir interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dasabuvir Sodium, Ombitasvir, Paritaprevir, Ritonavir interactionDaunorubicin, CytarabineVyxeos
How Daunorubicin, Cytarabine interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Daunorubicin, Cytarabine interactionDeferasiroxExjade, Jadenu
How Deferasirox interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Deferasirox interactionDehydrocholic Acid, Homatropine Methylbromide, PhenobarbitalG.B.S.
How Dehydrocholic Acid, Homatropine Methylbromide, Phenobarbital interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dehydrocholic Acid, Homatropine Methylbromide, Phenobarbital interactionDemeclocyclineDeclomycin
How Demeclocycline interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Demeclocycline interactionDesogestrel, Ethinyl EstradiolDesogen, Marvelon, Marvelon 21, Marvelon 28, Mircette, Ortho-Cept +2 more
How Desogestrel, Ethinyl Estradiol interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors +1 Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Desogestrel, Ethinyl Estradiol interactionDeucravacitinibSotyktu
How Deucravacitinib interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Deucravacitinib interactionDexamethasoneDecadron, Dexone, Dextenza, Dexycu, Hemady, Hexadrol +1 more
How Dexamethasone interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dexamethasone interactionDiclofenacZorvolex
How Diclofenac interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 2c9 (cyp2c9) Substrates, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diclofenac interactionDiclofenac PotassiumCambia, Cataflam, Cataflam IR, Voltaren Rapide, Voltarol Rapid
How Diclofenac Potassium interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diclofenac Potassium interactionDiclofenac SodiumAcoflam, Acoflam 75 SR, Acoflam Retard, Defenac, Defenac Retard, Defenac SR +40 more
How Diclofenac Sodium interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 2c9 (cyp2c9) Substrates, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diclofenac Sodium interactionDiclofenac Sodium, MisoprostolArthrotec 50, Arthrotec 75
How Diclofenac Sodium, Misoprostol interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diclofenac Sodium, Misoprostol interactionDiclofenac EpolamineFlector, Licart
How Diclofenac Epolamine interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 2c9 (cyp2c9) Substrates, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diclofenac Epolamine interactionDicyclomine, PhenobarbitalBentyl w/ Pb
How Dicyclomine, Phenobarbital interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dicyclomine, Phenobarbital interactionDiethylstilbestrol, MethyltestosteroneTylosterone
How Diethylstilbestrol, Methyltestosterone interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diethylstilbestrol, Methyltestosterone interactionDiroximel FumarateVumerity
How Diroximel Fumarate interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Diroximel Fumarate interactionDolutegravir, Emtricitabine, Tenofovir AlafenamideDolutegravir, Emtricitabine, Tenofovir Alafenamide
How Dolutegravir, Emtricitabine, Tenofovir Alafenamide interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dolutegravir, Emtricitabine, Tenofovir Alafenamide interactionDoxycyclineDoryx, Doxy, Doxy-D, Doxycin, Doxycycline Injection, Doxylin +6 more
How Doxycycline interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Doxycycline interactionDoxycycline HyclateActiclate, Acticlate Cap, Lymepak
How Doxycycline Hyclate interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Doxycycline Hyclate interactionDoxycycline MonohydrateErfacea
How Doxycycline Monohydrate interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Doxycycline Monohydrate interactionDoxycylineDoxychel
How Doxycyline interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Doxycyline interactionDronedaroneMultaq
How Dronedarone interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dronedarone interactionDrospirenone, EstetrolNextstellis
How Drospirenone, Estetrol interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Drospirenone, Estetrol interactionDrospirenone, Ethinyl EstradiolAngeliq, Gianvi, Yasmin
How Drospirenone, Ethinyl Estradiol interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Drospirenone, Ethinyl Estradiol interactionDuloxetineCymbalta, Drizalma Sprinkle, Irenka
How Duloxetine interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Duloxetine interactionDyphylline, Ephedrine, Guaifenesin, PhenobarbitalLufyllin-EPG
How Dyphylline, Ephedrine, Guaifenesin, Phenobarbital interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Dyphylline, Ephedrine, Guaifenesin, Phenobarbital interactionEfavirenzSustiva
How Efavirenz interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Efavirenz interactionEfavirenz, Lamivudine, Tenofovir Disoproxil FumarateSymfi
How Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate interacts with Ostagenin Max — through 1 ingredient. Tap an ingredient for the detail:
(2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inhibitors, Cytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full (2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide + Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Ostagenin Max with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
(2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide
Cytochrome P450 3A4 (Cyp3A4) Inducers
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Ostarine is partially metabolized by CYP3A4. Clinical research shows that taking rifampin, a potent inducer of CYP3A4, reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%.
Hepatotoxic Drugs
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Some clinical research shows that ostarine can increase alanine aminotransferase, a marker of liver damage, in some patients. Additionally, the U.S. Food and Drug Administration warns that supplements containing SARMs, such as ostarine, have been associated with reports of liver toxicity and there are at least two reports of drug-induced liver injury attributed to the use of ostarine.
Probenecid (Benemid)
Theoretically, concomitant use of ostarine with probenecid could increase the effects and adverse effects of ostarine.
Clinical research shows that probenecid increases ostarine levels and slows the clearance of ostarine, likely via inhibition of UDP-glucuronosyltransferase (UGT). Ostarine is partially metabolized by UGT.
Rifampin (Rifadin)
Theoretically, concomitant use of ostarine with rifampin could decrease the clinical effects of ostarine.
Clinical research shows that taking rifampin with ostarine reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%. Ostarine is partially metabolized by cytochrome P450 3A4 (CYP3A4), and rifampin is a potent CYP3A4 inducer.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Although in vitro research suggests that ostarine inhibits CYP2C9, more robust clinical research shows that ostarine does not significantly affect CYP2C9.
Cytochrome P450 3A4 (Cyp3A4) Inhibitors
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Ostarine is partially metabolized by CYP3A4. However, clinical research shows that taking itraconazole, a potent inhibitor of CYP3A4, had minimal effects on the levels of ostarine in the body.
Brand information
Manufacturer and brand details for Ostagenin Max, from the product label.
Ostagenin Max by EPG: Common Questions
Does Ostagenin Max by EPG interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Is Ostagenin Max approved by the FDA?
What are the most common side effects?
Can I take this while pregnant or breastfeeding?
Does this product actually work for muscle building or athletic performance?
Why is there such a large number of medication interactions?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Ostagenin Max is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Ostagenin Max’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
Ostagenin Max's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 10 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Ostarine 10 references
- Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
- Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
- Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
- Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 2013;14(4):335-45. PubMed
- Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II tri
- Coss CC, Jones A, Dalton JT. Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024 (enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. Invest New Drugs 2016;34(4):458-67. PubMed
- FDA. FDA Warns against using SARMs in body building products. October 2017. Available at: https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm.
- Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM. Drug-induced liver injury from enobosarm (ostarine), a selective androgen receptor modulator. ACG Case Rep J 2021;8(1):e00518. PubMed
- Kintz P, Gheddar L, Paradis C, et al. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- d) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516
- Weinblatt D, Roy S. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator. J Med Cases 2022;13(5):244-248. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC